Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Fidia Spa ( (IT:FDA) ).
Fidia has reported the conversion of two bonds from the seventh tranche of its convertible bond loan with warrants reserved to Global Growth Holding Limited, at a conversion price of €0.006 per share. The transaction resulted in the issuance of 3,333,333 new shares, which will be admitted directly to trading, and reflects ongoing execution of the company’s structured financing plan.
Following this latest conversion, the POC has been subscribed for a nominal €1.75 million, with €1.53 million of the related capital increase already subscribed and 22 bonds of the seventh tranche still outstanding. As a result, Fidia’s share capital rises by €20,000 to €11,377,761.90, and the total number of shares increases to 117,078,639, modestly diluting existing shareholders while strengthening the company’s equity base.
More about Fidia Spa
Fidia S.p.A., headquartered in Turin and listed on Euronext Milan, is a global leader in numerical control technology and high-performance integrated milling systems. The group focuses on advanced solutions for the mould sector serving the automotive industry and the aerospace sector, offering numerical controls, high-speed milling machines and CAM software for complex shapes.
Average Trading Volume: 3,211,415
Technical Sentiment Signal: Strong Sell
Current Market Cap: €532.3K
For detailed information about FDA stock, go to TipRanks’ Stock Analysis page.